NO994612D0 - Retinoid-related molecules for the treatment of non-insulin-dependent diabetes mellitus - Google Patents

Retinoid-related molecules for the treatment of non-insulin-dependent diabetes mellitus

Info

Publication number
NO994612D0
NO994612D0 NO994612A NO994612A NO994612D0 NO 994612 D0 NO994612 D0 NO 994612D0 NO 994612 A NO994612 A NO 994612A NO 994612 A NO994612 A NO 994612A NO 994612 D0 NO994612 D0 NO 994612D0
Authority
NO
Norway
Prior art keywords
retinoid
insulin
treatment
diabetes mellitus
dependent diabetes
Prior art date
Application number
NO994612A
Other languages
Norwegian (no)
Other versions
NO994612L (en
Inventor
Magnus Pfahl
Waldemar Lernhardt
Andrea Fanjol
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NO994612D0 publication Critical patent/NO994612D0/en
Publication of NO994612L publication Critical patent/NO994612L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
NO994612A 1997-03-24 1999-09-22 Retinoid-related molecules for the treatment of non-insulin-dependent diabetes mellitus NO994612L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3560497P 1997-03-24 1997-03-24
PCT/US1998/005591 WO1998042340A1 (en) 1997-03-24 1998-03-24 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus

Publications (2)

Publication Number Publication Date
NO994612D0 true NO994612D0 (en) 1999-09-22
NO994612L NO994612L (en) 1999-11-24

Family

ID=21883695

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994612A NO994612L (en) 1997-03-24 1999-09-22 Retinoid-related molecules for the treatment of non-insulin-dependent diabetes mellitus

Country Status (11)

Country Link
EP (1) EP1019049A1 (en)
JP (1) JP2001521551A (en)
KR (1) KR20010005678A (en)
CN (1) CN1256630A (en)
AU (1) AU6576398A (en)
BR (1) BR9808054A (en)
CA (1) CA2284192A1 (en)
IL (1) IL132032A0 (en)
NO (1) NO994612L (en)
NZ (1) NZ337927A (en)
WO (1) WO1998042340A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR023699A1 (en) * 1998-11-12 2002-09-04 Smithkline Beecham Corp A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INSULIN STABILIZER AND A PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION
DE69939485D1 (en) * 1998-11-12 2008-10-16 Smithkline Beecham Plc MEDICAMENT FOR THE TAXED RELEASE OF AN INSULIN SENSITIZER AND METFORMINE
WO2002100396A1 (en) * 2001-06-07 2002-12-19 Wyeth COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT
CN1921843A (en) * 2004-01-23 2007-02-28 独立行政法人科学技术振兴机构 Retinoic acid-containing remedy for diabetes
CN106211757B (en) * 2014-01-17 2022-06-07 康奈尔大学 Methods of treating metabolic syndrome-related conditions using retinoic acid receptor agonists
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0465508T3 (en) * 1989-03-08 2000-08-07 Univ Virginia Dietary Supplement for Insulin Resistant Diabetics
FR2695317B1 (en) * 1992-09-07 1995-03-10 Monal Lab Composition capable of stimulating the secretion of insulin intended for the treatment of non-insulin-dependent diabetes.
DE69423806T2 (en) * 1993-01-22 2000-08-17 Kanegafuchi Chemical Ind Therapeutic agent for NIDDM
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5444086A (en) * 1994-03-31 1995-08-22 American Home Products Corporation Naphthalenylmethyl thiophenones as antihyperglycemic agents

Also Published As

Publication number Publication date
CA2284192A1 (en) 1998-10-01
KR20010005678A (en) 2001-01-15
IL132032A0 (en) 2001-03-19
BR9808054A (en) 2000-11-07
AU6576398A (en) 1998-10-20
EP1019049A1 (en) 2000-07-19
NZ337927A (en) 2000-11-24
CN1256630A (en) 2000-06-14
NO994612L (en) 1999-11-24
JP2001521551A (en) 2001-11-06
WO1998042340A1 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
NO976063D0 (en) Procedure for the treatment of diabetes
DE69817446D1 (en) Treatment of diabetes
NO20006630D0 (en) Pharmaceutical composition for the treatment of diabetes
DE69534360D1 (en) Central source of several wavelengths
ID16493A (en) TREATMENT OF MATERIALS CONTAINING THE SOLIDITY TAKEN FROM EFLUENTS
FI964314A (en) Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
NO965377L (en) Indolinone compounds for the treatment of diseases
DE69507757D1 (en) Divided substrate treatment chamber
FI953180A0 (en) Compositions for the treatment of diabetic complications
IS2011B (en) A compound for the treatment of cancer
NO20022087L (en) Procedure for the treatment of diabetes
DE69829763D1 (en) USE OF TETRAHYDOLIPSTATIN IN THE TREATMENT OF DIABETES TYPE II
DE69812708D1 (en) NEW MEDICAMENT CONTAINING URIDINTRIPHOSPHATE
NO994612D0 (en) Retinoid-related molecules for the treatment of non-insulin-dependent diabetes mellitus
DE69510594T2 (en) Manufacture of magnetostrictive material
AU2205099A (en) Chimeric proteins for the treatment of diabetes
DE69800559D1 (en) Ferrielectric liquid crystal compound
ID22437A (en) UNIT OF THE STIRRER
DK0869785T3 (en) 4-Hydroxycoumarin-3-carboxyamides for the treatment of non-insulin-dependent diabetes mellitus
NO20012563D0 (en) Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus
NO973003D0 (en) Synergistic combinations of 2- (thiocyanomethylthio) benzothiazole and thiophanate compounds useful as fungicides
NO993549D0 (en) Imino-aza-anthracycline derivatives for the treatment of amyloidosis
NO943723D0 (en) Use of quinoline-3-carboxamide compounds for the treatment of diabetes
FI952953A (en) Substances for the treatment of metabolic skeletal disorders
DE69800359T2 (en) Antiferroelectric liquid crystal compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application